Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/18/2025

Diagnosis and Monitoring of Diabetes

HbA1c Measurement Considerations

  • The American Diabetes Association recommends using plasma glucose criteria exclusively for diabetes diagnosis in patients with conditions affecting red blood cell turnover, such as hemoglobin variants or recent blood transfusions, with a moderate level of evidence 1, 2, 3, 4, 5
  • Patients with certain conditions, including hemodialysis, hypertriglyceridemia, hyperbilirubinemia, uremia, chronic alcoholism, chronic ingestion of salicylates, and opiate addiction, may have inaccurate HbA1c results due to interference with assay methods, highlighting the need for alternative monitoring methods 6, 7, 8
  • Conditions that can cause falsely decreased HbA1c values include hemolytic anemia, sickle cell disease/trait, glucose-6-phosphate dehydrogenase deficiency, recent blood loss or transfusion, pregnancy, hemodialysis/end-stage kidney disease, erythropoietin therapy, and HIV treated with certain protease inhibitors and nucleoside reverse transcriptase inhibitors 7, 1, 9, 10, 3
  • Iron deficiency anemia and vitamin B12 or folate deficiency can increase HbA1c values despite normal blood glucose levels, while over 700 hemoglobin variants can interfere with HbA1c measurements, with some variants affecting certain assay methods more than others, and ethnic variations exist 7, 1, 9, 3
  • The National Glycohemoglobin Standardization Program (NGSP) certifies A1c assays, and it is recommended to use these certified assays to ensure accurate results, with a high level of evidence 6, 3
  • For patients with suspected hemoglobin variants, boronate affinity chromatography methods may be more reliable, although this is not explicitly stated by a specific guideline society 6
  • Alternative glycemic markers, such as fructosamine and glycated albumin, can provide a more comprehensive understanding of a patient's glycemic control, especially in patients with conditions that affect HbA1c results, with a moderate level of evidence 11, 12, 3
  • Continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG) can help validate HbA1c results and provide a more comprehensive understanding of a patient's glycemic control, with a moderate level of evidence 13, 11, 14, 9, 15, 3
  • Clinicians should assess for risk factors of falsely elevated HbA1c, such as anemia, hemoglobinopathies, or ethnic background with higher risk, and consider alternative testing methods if hemoglobin is <10 g/dL or suspected interference, with a moderate to high level of evidence 7, 1, 3, 2, 6, 4
  • When a discrepancy is detected between HbA1c and plasma glucose levels, comparing HbA1c with estimated A1c from glucose monitoring and considering alternative glycemic markers can help resolve the issue, with a high level of evidence 13, 2, 6, 3

Interpretation of HbA1c Results

  • Clinicians should be aware of the potential for misinterpreting low HbA1C values in patients with hemolytic anemia, which may lead to undertreatment of diabetes and increased risk of complications, emphasizing the importance of using multiple monitoring methods for comprehensive assessment, with a high level of evidence 7, 13, 2, 6
  • If a discrepancy is detected between HbA1c and plasma glucose levels, clinicians should consider alternative glycemic markers and adjust treatment plans accordingly, with a high level of evidence 13, 2, 6, 3

Alternative Glycemic Markers

Marker Description Level of Evidence
Fructosamine Reflects glycemic control over 2-3 weeks, less affected by red blood cell lifespan, but can be impacted by hypoalbuminemia Low to Moderate [11, 12, 3]
Glycated Albumin More reliable in patients with hemolytic conditions, less likely to be affected by confounding factors except low albumin levels Moderate [11, 12, 3]
Continuous Glucose Monitoring (CGM) Provides a comprehensive understanding of a patient's glycemic control, can help validate HbA1c results Moderate [13, 11, 14, 9, 15, 3]
Self-Monitoring of Blood Glucose (SMBG) Provides a comprehensive understanding of a patient's glycemic control, can help validate HbA1c results Moderate [13, 11, 14, 9, 15, 3]

REFERENCES